Irish drugmaker Elan Corp. PLC reported a smaller second-quarter loss Wednesday compared with a year ago, when it set aside money to cover an eventual legal settlement.
Popular Posts:
- Hospital CEO Takes on Health Care Reform
- Analyst gauges financial loss from Novartis recall
- Dendreon takes bigger 3Q loss, Provenge sales rise
- Hospital CEO Takes on Health Care Reform
- Health Insurance Reform: Secretary Sebelius Takes Your Questions …